Cargando…

Breast cancer patients’ clinical outcome measures are associated with Src kinase family member expression

BACKGROUND: This study determined mRNA expression levels for Src kinase family (SFK) members in breast tissue specimens and assessed protein expression levels of prominent SFK members in invasive breast cancer to establish associations with clinical outcome. Ki67 was investigated to determine associ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elsberger, B, Fullerton, R, Zino, S, Jordan, F, Mitchell, T J, Brunton, V G, Mallon, E A, Shiels, P G, Edwards, J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966624/ https://www.ncbi.nlm.nih.gov/pubmed/20717116 http://dx.doi.org/10.1038/sj.bjc.6605829

Ejemplares similares

Expression and prognostic significance of Src family members in renal clear cell carcinoma
por: Qayyum, T, et al.
Publicado: (2012)

Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer
por: Ohotski, J, et al.
Publicado: (2012)

Is there an association with phosphorylation and dephosphorylation of Src kinase at tyrosine 530 and breast cancer patient disease-specific survival
por: Elsberger, B, et al.
Publicado: (2010)

Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer
por: Mohammed, Z M A, et al.
Publicado: (2012)

Altered sirtuin expression is associated with node-positive breast cancer
por: Ashraf, N, et al.
Publicado: (2006)

Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases
por: Lesslie, D P, et al.
Publicado: (2006)

Episodic Src activation in uveal melanoma revealed by kinase activity profiling
por: Maat, W, et al.
Publicado: (2009)

The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer
por: Mohammed, Z M A, et al.
Publicado: (2013)

The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer
por: Mohammed, Z MA, et al.
Publicado: (2012)

The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder
por: Qayyum, T, et al.
Publicado: (2012)

HOXC11–SRC-1 regulation of S100beta in cutaneous melanoma: new targets for the kinase inhibitor dasatinib
por: deBlacam, C, et al.
Publicado: (2011)

The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone
por: Campbell, Esther J, et al.
Publicado: (2016)

Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA
por: McKiernan, E, et al.
Publicado: (2008)

Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma
por: Rand, V, et al.
Publicado: (2008)

Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity
por: Wilson, G R, et al.
Publicado: (2006)

The in situ local immune response, tumour senescence and proliferation in colorectal cancer
por: Roxburgh, C S, et al.
Publicado: (2013)

Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer
por: Milde-Langosch, K, et al.
Publicado: (2005)

Specific induction of pp125 focal adhesion kinase in human breast cancer
por: Watermann, D O, et al.
Publicado: (2005)

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients
por: Aubele, M, et al.
Publicado: (2008)

Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients
por: van Nes, J G H, et al.
Publicado: (2009)

Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial
por: Bartlett, J M S, et al.
Publicado: (2013)

Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
por: Beetham, Henry, et al.
Publicado: (2022)

VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo
por: Rennel, E S, et al.
Publicado: (2009)

Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression
por: Canel, M, et al.
Publicado: (2008)

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas
por: Aubele, M, et al.
Publicado: (2007)

Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction
por: Baneshi, M R, et al.
Publicado: (2010)

Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer
por: Kwon, C H, et al.
Publicado: (2014)

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
por: Ali, H R, et al.
Publicado: (2012)

Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
por: Kumar, R, et al.
Publicado: (2009)

Is PTEN loss associated with clinical outcome measures in human prostate cancer?
por: McCall, P, et al.
Publicado: (2008)

Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer
por: Doherty, G A, et al.
Publicado: (2009)

ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines
por: Khursheed, M, et al.
Publicado: (2013)

Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis
por: Warneke, V S, et al.
Publicado: (2013)

Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response
por: Al-kaabi, M M, et al.
Publicado: (2015)

The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer
por: Gujam, F J A, et al.
Publicado: (2015)

The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer
por: Gujam, F J A, et al.
Publicado: (2014)

MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells
por: Cui, Yu-Xin, et al.
Publicado: (2017)

Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements
por: You, B, et al.
Publicado: (2013)

Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
por: Engels, C C, et al.
Publicado: (2014)

Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays
por: Akbar, Shazia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9492f0leae05100iate31c9gda